Smart Insulin Pens Market Report 2026

Smart Insulin Pens Market Overview

• Smart Insulin Pens market size has reached to $0.11 billion in 2025 • Expected to grow to $0.16 billion in 2030 at a compound annual growth rate (CAGR) of 6.8% • Growth Driver: Rising Global Diabetic Population Driving Market Growth Due To Increased Adoption And Advanced Diabetes Management • Market Trend: Embedding AI?Driven Dosing Guidance And Missed?Dose Corrections Through Smart MDI Systems • North America was the largest region in 2025 and Western Europe is the fastest growing region.

What Is Covered Under Smart Insulin Pens Market?

Smart insulin pens are insulin delivery devices that keep track of the volume, time, and type of dosage. These devices may also perform tasks such as generating reports to be shared with healthcare professionals. The main types of smart insulin pens are first-generation pens and second-generation pens (Bluetooth enabled, USB connected). The second-generation smart insulin pens are devices that are engineered with Bluetooth or USB features to enable closer monitoring. The smart insulin pens are either prefilled or reusable and is used to treat type 1 diabetes and type 2 diabetes. The various end-users of smart insulin pens are hospitals and clinics, ambulatory surgical centers, and home care settings.

What Is The Smart Insulin Pens Market Growth Forecast?

The smart insulin pens market size is expected to see strong growth in the next few years. It will grow to $0.16 billion in 2030 at a compound annual growth rate (CAGR) of 6.8%. The growth in the forecast period can be attributed to increasing integration with digital diabetes ecosystems, rising adoption of personalized insulin therapy, expansion of remote patient monitoring, growing focus on data-driven diabetes care, increasing investments in smart drug delivery technologies. Major trends in the forecast period include increasing adoption of connected insulin delivery devices, rising use of real-time dose tracking solutions, growing demand for home-based diabetes management, expansion of mobile app-integrated insulin pens, enhanced focus on patient adherence and safety.

Global Smart Insulin Pens Market Segmentation

1) By Type: First Generation Pens, Second Generation Pens 2) By Usability: Prefilled, Reusable 3) By Application: Type 1 Diabetes, Type 2 Diabetes 4) By End User: Hospitals & Clinics, Ambulatory Surgical Centres, Home Care Settings Subsegments: 1) By First Generation Pens: Basic Smart Insulin Pens With Standard Features, Simple Connectivity to Mobile Apps for Tracking and Logging Insulin Doses 2) By Second Generation Pens: Advanced Smart Insulin Pens With Enhanced Features, Real-Time Data Sharing With Healthcare Providers and Caregivers, Sophisticated Mobile Applications for Comprehensive Diabetes Management

What Is The Driver Of The Smart Insulin Pens Market?

The increasing global diabetic population is expected to propel the growth of the smart insulin pen market going forward. The diabetic population refers to individuals who have been diagnosed with diabetes; a chronic medical condition characterized by elevated levels of blood glucose. The rise in the diabetic population is due to the increasing prevalence of obesity and physical inactivity globally, which are the primary drivers of Type 2 diabetes. Smart insulin pens improve diabetes management by offering precise insulin dosage tracking, reminders, and data integration, enhancing treatment adherence and overall glycemic control for individuals with diabetes. For instance, in 2025, according to the International Diabetes Federation, a Belgium-based health organization, in 2024, around 589 million adults aged 20-79 were living with diabetes, with the total number projected to reach 853 million by 2050 and with more than 4 in 5 adults with diabetes residing in low and middle income countries. Therefore, the increasing global diabetic population is driving the growth of the smart insulin pen industry.

Key Players In The Global Smart Insulin Pens Market

Major companies operating in the smart insulin pens market are Companion Medical, Novo Nordisk A/S, F. Hoffmann-La Roche AG, Emperra GmbH E-Health Technologies, Diamesco Co. Ltd., Digital Medics Pvt Ltd., Bigfoot Biomedical, Diabnext, Insulet Corporation, Sanofi India, Becton Dickinson, Biocon Ltd, Johnson & Johnson, Terumo, NIPRO, Medtronic PLC, Ypsomed Holding AG, Patients Pending Ltd, Dexcom, Insujet, Eli Lilly, Abbott Laboratories, Tandem Diabetes Care Inc.

Global Smart Insulin Pens Market Trends and Insights

Major companies operating in the smart insulin pen market are innovating integrated systems that combine real‑time glucose monitoring, dose calculation, and missed‑dose detection to simplify insulin management and reduce hypoglycemia risks. These integrated systems leverage Bluetooth‑enabled pens, mobile apps, and compact continuous glucose monitors to provide personalized dosing insights, correct dosing errors, and improve overall glycemic control. For instance, in December 2024, Medtronic, a US-based medical technology, services, and solutions company, launched its Smart MDI System, a smart insulin pen with the Simplera CGM, offering real‑time, personalized dosing recommendations. This system is the first of its kind to provide missed‑meal dose detection and correction suggestions, helping patients catch and correct unadministered or inaccurate insulin injections. Real-world data showed that users who consistently responded to these actionable alerts achieved Time in Range (TIR) levels of up to 67-71%, demonstrating the potential of this technology to improve glucose control.

What Are Latest Mergers And Acquisitions In The Smart Insulin Pens Market?

In October 2023, Novo Nordisk A/S, a Denmark-based pharmaceutical company, acquired Biocorp for $164.5 million. The acquisition is expected to help Novo Nordisk further invest in Biocorp's device development and accelerate its ambitions within devices and delivery solutions. Biocorp is a France-based medical device company that specializes in the development and manufacturing of drug-delivery systems and medical devices.

Regional Outlook

North America was the largest region in the smart insulin pens market in 2025. Western Europe was the second largest region in the global smart insulin pens market share. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

What Defines the Smart Insulin Pens Market?

The smart insulins pens market consists of sales of instruments such as first-generation pens and second-generation pens (Bluetooth enabled, USB connected). Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.